Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Remimazolam tosylate vs propofol anesthesia in kidney transplantation
ChiCTR2400083451Phase 4Not yet recruiting
- Sponsor
- First Affiliated Hospital, Zhejiang University School of Medicine
- Start
- Apr 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4 trial of remimazolam in chronic kidney disease (CKD) (2 arms), sponsored by First Affiliated Hospital, Zhejiang University School of Medicine. Primary endpoints: Perioperative sedation and recovery, Use of remedial sedation and 1 more. Planned start Apr 2024; status: not yet recruiting.
02
Drugs
remimazolam
03
Conditions
chronic kidney disease (CKD)
Beyond the preview
Go deeper on ChiCTR2400083451.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2400083451.